What is Surglogs?
Founded in 2015 and headquartered in Coronado, California, Surglogs provides a comprehensive suite of regulatory compliance software tailored for healthcare facilities. The platform serves as a critical digital bridge, automating complex documentation and audit processes that are traditionally manual and error-prone. By digitizing compliance workflows, Surglogs enables healthcare providers to focus on patient outcomes while maintaining rigorous adherence to industry standards. The company operates at the intersection of health-tech and enterprise SaaS, addressing the persistent pain points of administrative burden and regulatory risk in hospitals and clinics. Its market position is defined by its ability to integrate into existing clinical environments, providing real-time visibility into compliance status and operational efficiency.
How much funding has Surglogs raised?
Surglogs has raised a total of $16.5M across 2 funding rounds:
Angel/Seed
$6M
Series A
$10.5M
Angel/Seed (2019): $6M, investors not publicly disclosed
Series A (2021): $10.5M led by OpenOcean, Credoventures, and 8VC
Key Investors in Surglogs
OpenOcean
OpenOcean is an early-stage venture capital firm investing across Europe with offices in London, Helsinki, and Amsterdam. The firm engages with founders to build and scale global companies delivering data-intensive software solutions.
Credoventures
Credo Ventures is a venture capital fund that supports ambitious founders from Central and Eastern Europe, focusing on pre-seed investments and fostering innovation in the region.
8VC
8VC is a leading technology investment firm managing $3.6 billion in committed capital, focusing on smart enterprise platforms across industries including healthcare and logistics.
What's next for Surglogs?
With the infusion of this latest capital, Surglogs is poised to enter a new phase of strategic expansion. The company is expected to prioritize the enhancement of its core software architecture, potentially integrating advanced data analytics and predictive compliance modeling to further differentiate its offering. As the healthcare sector continues to digitize, the demand for robust, automated regulatory tools is projected to rise, providing Surglogs with a significant runway for market penetration. Future initiatives will likely focus on scaling sales and marketing efforts to capture a larger share of the enterprise healthcare market, while simultaneously exploring potential partnerships that could broaden its service ecosystem. The firm remains focused on its mission to simplify the complexities of healthcare regulation through innovative, data-driven software solutions.
See full Surglogs company page
